[China BD 2025] Degron Therapeutics and MSD enters a License on FIC Molecular Glue Degraders

Announced Date: 2025-11-13 (November 11, 2025)

Licensor (Seller): Degron Therapeutics (China)

Licensee (Buyer):  MSD R&D (China)

.

Asset Modality: Molecular Glue Degraders

.

Scope of Authority:

Leverage Degron’s GlueXplorer platform and MSD’s clinical expertise in oncology and rare diseases

.

Payment Detail:

Undisclosed.

.

Link:

Degron Therapeutics, MSD R&D, and the Next Generation of Molecular Glue Degraders – Insight, China’s Pharmaceutical Industry (flcube.com)

.

Note:

Chinese Name of Degron Therapeutics 达歌生物